Veterinary Pain Management Drugs Market is expected to grow with a CAGR of 7% during the forecast period of 2018 to 2025.
CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC DESK RESEARCH
1.1.2. ERC DATA SYNTHESIS
1.1.3. DATA VALIDATION AND MARKET FEEDBACK
1.1.4. ERC DATA SOURCES
CHAPTER 2. VETERINARY PAIN MANAGEMENT DRUGS MARKET OVERVIEW
2.1. VETERINARY PAIN MANAGEMENT DRUGS MARKET INTRODUCTION
2.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION (VOLUME) AND GROWTH RATE (%), (2017-2025)
2.3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS CAPACITY (VOLUME) AND GROWTH RATE (%), (2017-2025)
2.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)
2.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS CONSUMPTION (VOLUME) AND GROWTH RATE (%), (2017-2025)
CHAPTER 3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY PRODUCT TYPE, 2017-2025
3.1. OPIOIDS
3.2. 2-ADRENERGIC AGONISTS
3.3. LOCAL ANESTHETICS
3.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY PRODUCT TYPE, 2017-2025
3.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY PRODUCT TYPE, 2017-2025
3.4.2. OPIOIDS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.3. 2-ADRENERGIC AGONISTS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.4. LOCAL ANESTHETICS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION BY PRODUCT TYPE, 2017-2025
3.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY PRODUCT TYPE, 2017-2025
3.5.2. OPIOIDS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
3.5.3. 2-ADRENERGIC AGONISTS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
3.5.4. LOCAL ANESTHETICS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for other product type segments.
CHAPTER 4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY APPLICATION, 2017-2025
4.1. VETERINARY HOSPITALS
4.2. VETERINARY CLINICS
4.3. RETAIL
4.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY APPLICATION, 2017-2025
4.4.2. VETERINARY HOSPITALS MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.3. VETERINARY CLINICS MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.4. RETAIL MARKET REVENUE AND GROWTH RATE, 2017-2025
4.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY APPLICATION, 2017-2025
4.5.2. VETERINARY HOSPITALS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
4.5.3. VETERINARY CLINICS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
4.5.4. RETAIL MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for route of administration and animal type segments.
CHAPTER 5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. CANADA
5.1.3. MEXICO
5.2. EUROPE
5.2.1. U.K.
5.2.2. FRANCE
5.2.3. GERMANY
5.2.4. ITALY
5.2.5. SPAIN
5.2.6. REST OF EUROPE
5.3. ASIA PACIFIC
5.3.1. CHINA
5.3.2. JAPAN
5.3.3. INDIA
5.3.4. KOREA
5.3.5. REST OF APAC
5.4. SOUTH AMERICA
5.4.1. BRAZIL
5.4.2. REST OF SOUTH AMERICA
5.5. REST OF THE WORLD
5.5.1. MIDDLE EAST
5.5.2. AFRICA
5.6. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY REGION, 2017-2025
5.6.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025
CHAPTER 6. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
6.1.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
6.1.3. NORTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.4. EUROPE MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.5. ASIA PACIFIC MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.6. SOUTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.7. REST OF THE WORLD MARKET PRODUCTION AND CONSUMPTION, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION (VOLUME) AND SHARE (%) BY MANUFACTURERS (2017-2025)
8.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS REVENUE (MILLION USD) AND SHARE (%) BY MANUFACTURERS (2017-2025)
8.3. VETERINARY PAIN MANAGEMENT DRUGS MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE (%) OF TOP 3 MANUFACTURERS
8.3.2. VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE (%) OF TOP 5 MANUFACTURERS
CHAPTER 9. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MANUFACTURERS ANALYSIS
9.1. BOEHRINGER INGELHEIM
9.1.1. BUSINESS OVERVIEW
9.1.2. COMPANY BASIC INFORMATION
9.1.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.1.4. BOEHRINGER INGELHEIM VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.2. ZOETIS
9.2.1. BUSINESS OVERVIEW
9.2.2. COMPANY BASIC INFORMATION
9.2.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.2.4. ZOETIS VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.3. ELANCO
9.3.1. BUSINESS OVERVIEW
9.3.2. COMPANY BASIC INFORMATION
9.3.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.3.4. ELANCO VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.4. MERCK ANIMAL HEALTH
9.4.1. BUSINESS OVERVIEW
9.4.2. COMPANY BASIC INFORMATION
9.4.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.4.4. MERCK ANIMAL HEALTH VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.5. BAYER
9.5.1. BUSINESS OVERVIEW
9.5.2. COMPANY BASIC INFORMATION
9.5.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.5.4. BAYER VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.6. VETOQUINOL
9.6.1. BUSINESS OVERVIEW
9.6.2. COMPANY BASIC INFORMATION
9.6.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.6.4. VETOQUINOL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.7. NORBROOK LABORATORIES
9.7.1. BUSINESS OVERVIEW
9.7.2. COMPANY BASIC INFORMATION
9.7.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.7.4. NORBROOK LABORATORIES VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.8. CEVA SANTÉ ANIMALE
9.8.1. BUSINESS OVERVIEW
9.8.2. COMPANY BASIC INFORMATION
9.8.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.8.4. CEVA SANTÉ ANIMALE VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.9. DECHRA PHARMACEUTICALS
9.9.1. BUSINESS OVERVIEW
9.9.2. COMPANY BASIC INFORMATION
9.9.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.9.4. DECHRA PHARMACEUTICALS VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
9.10. CHANELLE
9.10.1. BUSINESS OVERVIEW
9.10.2. COMPANY BASIC INFORMATION
9.10.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.10.4. CHANELLE VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
CHAPTER 10. VETERINARY PAIN MANAGEMENT DRUGS MARKET VALUE CHAIN ANALYSIS
10.1. VETERINARY PAIN MANAGEMENT DRUGS INDUSTRIAL CHAIN ANALYSIS
10.2. VETERINARY PAIN MANAGEMENT DRUGS KEY RAW MATERIALS ANALYSIS
10.2.1. KEY RAW MATERIALS
10.2.2. PRICE TREND OF KEY RAW MATERIALS
10.2.3. KEY SUPPLIERS OF RAW MATERIALS